Ex parte LAWSON et al. - Page 2


                     Appeal No. 1996-2400                                                                                                                                              
                     Application 08/245,145                                                                                                                                            

                     sustain the ground of rejection of claim 16 under § 103 over Faircloth et al. (Office action of December                                                          
                     13, 1994 (Paper No. 7; pages 3-4); answer, pages 3-6).  It is well settled that the examiner must                                                                 
                     satisfy his burden of establishing a prima facie case of obviousness by showing some objective                                                                    
                     teaching or suggestion in the applied prior art taken as a whole or that knowledge generally available to                                                         
                     one of ordinary skill in the art would have led that person to the claimed invention, including each and                                                          
                     every limitation of the claims, without recourse to the teachings in appellants' disclosure.  See generally                                                       
                     In re Oetiker, 977 F.2d 1443, 1447-48, 24 USPQ2d 1443, 1446-47 (Fed. Cir. 1992) (Nies, J.,                                                                        
                     concurring); In re Dow Chemical Co., 837 F.2d 469, 473, 5 USPQ2d 1529, 1531(Fed. Cir. 1988)                                                                       
                                We construe claim 16 to specify a solution that comprises at least water as a solvent, an                                                              
                     organophosphorus scale inhibitor selected from the group consisting of nitrilotri(methylene phosphonic                                                            
                     acid), diethylenetriaminepenta(methylene phosphonic acid) and salts thereof with monovalent cations in                                                            
                     an unspecified amount, and sodium chloride in an amount of about 12 to about 14% by weight of the                                                                 
                     scale inhibitor solution, and that can contain additional ingredients, such as the precursors of Faircloth et                                                     
                     al. and formation brine, in view of the transitional term “comprising.”  Exxon Chemical Patents Inc. v.                                                           
                     Lubrizol Corp., 64 F.3d 1553, 1555, 35 USPQ2d 1801, 1802 (Fed. Cir. 1995) (“The claimed                                                                           
                     composition is defined as comprising - meaning containing at least - five specific ingredients.”); In re                                                          
                     Baxter, 656 F.2d 679, 686-87, 210 USPQ 795, 802-03 (CCPA 1981) (“As long as one of the                                                                            
                     monomers in the reaction is propylene, any other monomer may be present, because the term                                                                         
                     ‘comprises’ permits the inclusion of other steps, elements, or materials.”).  Thus, the composition as                                                            
                     claimed exists whenever the three specified ingredients are present, regardless of the presence of other                                                          
                     ingredients.  See Exxon Chemical Patents, 64 F.3d at 1555-58, 35 USPQ2d at 1802-05                                                                                
                     (“Consequently, as properly construed, Exxon’s claims are to a composition that contains the specified                                                            
                     ingredients at any time from the moment at which the ingredients are mixed together.”).                                                                           
                                The examiner contends that one of ordinary skill in this art would have known that “the more                                                           
                     concentrated salt solutions would possess more dissolving ability with respect to dissolving the                                                                  
                     formation” (answer, page 5).  Thus, the examiner alleges that Faircloth et al. would have motivated that                                                          
                     person to employ a higher concentration of sodium chloride in the scale inhibitor solutions of the                                                                


                                                                                        - 2 -                                                                                          




Page:  Previous  1  2  3  4  5  Next 

Last modified: November 3, 2007